SYNERGISM OF THE ANTINEOPLASTIC ACTIVITY OF CYTOSINE ARABINOSIDE BY PORFIROMYCIN.
D000818:Animals; D000900:Anti-Bacterial Agents; D000970:Antineoplastic Agents; D001835:Body Weight; D003561:Cytarabine; D003596:Cytosine; D007938:Leukemia; D007939:Leukemia L1210; D007942:Leukemia, Experimental; D051379:Mice; D016685:Mitomycin; D008937:Mitomycins; D009369:Neoplasms / Q000628:therapy*; D009374:Neoplasms, Experimental; D009705:Nucleosides; D010600:Pharmacology; D011160:Porfiromycin; D012106:Research; D013534:Survival
D000900:Anti-Bacterial Agents; D000970:Antineoplastic Agents; D008937:Mitomycins; D009705:Nucleosides; D003561:Cytarabine; D016685:Mitomycin; D003596:Cytosine; D011160:Porfiromycin
ANTIBIOTICS; ANTINEOPLASTIC AGENTS; BODY WEIGHT; CYTOSINE; EXPERIMENTAL LAB STUDY; LEUKEMIA L1210; LEUKEMIA, EXPERIMENTAL; MICE; MITOMYCIN; NEOPLASM THERAPY; NEOPLASMS, EXPERIMENTAL; NUCLEOSIDES; PHARMACOLOGY; SURVIVAL